Sub-optimal vitamin B-12 levels among ART-naïve HIV-positive individuals in an urban cohort in Uganda

Aggrey S Semeere, Damalie Nakanjako, Henry Ddungu, Andrew Kambugu, Yukari C Manabe, Robert Colebunders, Aggrey S Semeere, Damalie Nakanjako, Henry Ddungu, Andrew Kambugu, Yukari C Manabe, Robert Colebunders

Abstract

Malnutrition is common among HIV-infected individuals and is often accompanied by low serum levels of micronutrients. Vitamin B-12 deficiency has been associated with various factors including faster HIV disease progression and CD4 depletion in resource-rich settings. To describe prevalence and factors associated with sub-optimal vitamin B-12 levels among HIV-infected antiretroviral therapy (ART) naïve adults in a resource-poor setting, we performed a cross-sectional study with a retrospective chart review among individuals attending either the Mulago-Mbarara teaching hospitals' Joint AIDS Program (MJAP) or the Infectious Diseases Institute (IDI) clinics, in Kampala, Uganda. Logistic regression was used to determine factors associated with sub-optimal vitamin B-12. The mean vitamin B-12 level was 384 pg/ml, normal range (200-900). Sub-optimal vitamin B-12 levels (<300 pg/ml) were found in 75/204 (36.8%). Twenty-one of 204 (10.3%) had vitamin B-12 deficiency (<200 pg/ml) while 54/204 (26.5%) had marginal depletion (200-300 pg/ml). Irritable mood was observed more among individuals with sub-optimal vitamin B-12 levels (OR 2.5, 95% CI; 1.1-5.6, P=0.03). Increasing MCV was associated with decreasing serum B-12 category; 86.9 fl (± 5.1) vs. 83 fl (± 8.4) vs. 82 fl (± 8.4) for B-12 deficiency, marginal and normal B-12 categories respectively (test for trend, P=0.017). Compared to normal B-12, individuals with vitamin B-12 deficiency had a longer known duration of HIV infection: 42.2 months (± 27.1) vs. 29.4 months (± 23.8; P=0.02). Participants eligible for ART (CD4<350 cells/µl) with sub-optimal B-12 had a higher mean rate of CD4 decline compared to counterparts with normal B-12; 118 (± 145) vs. 22 (± 115) cells/µl/year, P=0.01 respectively. The prevalence of a sub-optimal vitamin B-12 was high in this HIV-infected, ART-naïve adult clinic population in urban Uganda. We recommend prospective studies to further clarify the causal relationships of sub-optimal vitamin B-12, and explore the role of vitamin B-12 supplementation in immune recovery.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Coodley GO, Coodley MK, Nelson HD, Loveless MO. Micronutrient concentrations in the HIV wasting syndrome. AIDS. 1993;7:1595–1600.
    1. Tang AM, Lanzillotti J, Hendricks K, Gerrior J, Ghosh M, et al. Micronutrients: current issues for HIV care providers. AIDS. 2005;19:847–861.
    1. James JS. Low vitamin B-12 blood levels associated with faster progression to AIDS. AIDS Treat News. 1997. pp. 3–4.
    1. Hepburn MJ, Dyal K, Runser LA, Barfield RL, Hepburn LM, et al. Low serum vitamin B12 levels in an outpatient HIV-infected population. International Journal of STD and AIDS. 2004;15:127–133.
    1. Allen LH. How common is vitamin B-12 deficiency? The American Journal of Clincal Nutrition. 2009;89(suppl):693S–696S.
    1. Paltiel O, Falutz J, Veilleux M, Rosenblatt DS, Gordon K. Clinical correlates of subnormal vitamin B12 levels in patients infected with the human immunodeficiency virus. Am J Hematol. 1995;49:318–322.
    1. Balt CA. An investigation of the relationship between vitamin B12 deficiency and HIV infection. Journal of the Association of nurses AIDS Care 11: 24–28, 31–35. 2000.
    1. Lindenbaum J, Healton EB, Savage DG, Brust JC, Garrett TJ, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1988;318:1720–1728.
    1. Beach RS, Morgan R, Wilkie F, Mantero-Atienza E, Blaney N, et al. Plasma vitamin B12 level as a potential cofactor in studies of human immunodeficiency virus type 1-related cognitive changes. Arch Neurol. 1992;49:501–506.
    1. Kieburtz KD, Giang DW, Schiffer RB, Vakil N. Abnormal vitamin B12 metabolism in human immunodeficiency virus infection. Association with neurological dysfunction. Arch Neurol. 1991;48:312–314.
    1. WHO. All Participants in the Consulation: Conclusions Of a WHO Technical Consultation on Folate and Vitamin B12 Deficiencies. s238-s246 p. 2008.
    1. Friis H. Micronutrients and HIV infection: a review of current evidence. Durban, South Africa: World Health Organisation. 26–28 p. 2005.
    1. Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med. 2004;351:23–32.
    1. Erkurt MA, Aydogdu I, Dikilitas M, Kuku I, Kaya E, et al. Effects of cyanocobalamin on immunity in patients with pernicious anemia. Med Princ Pract. 2008;17:131–135.
    1. McLean ED, Allen LH, Neumann CG, Peerson JM, Siekmann JH, et al. Low plasma vitamin B-12 in Kenyan school children is highly prevalent and improved by supplemental animal source foods. J Nutr. 2007;137:676–682.
    1. Gibson RS, Abebe Y, Stabler S, Allen RH, Westcott JE, et al. Zinc, gravida, infection, and iron, but not vitamin B-12 or folate status, predict hemoglobin during pregnancy in Southern Ethiopia. J Nutr. 2008;138:581–586.
    1. Galukande M, Jombwe J, Fualal J, Baingana R, Gakwaya A. Reference values for serum levels of folic acid and vitamin B12 in a young adult Ugandan population. Afr Health Sci. 2011;11:240–243.
    1. Remacha AF, Cadafalch J. Cobalamin deficiency in patients infected with the human immunodeficiency virus. Semin Hematol. 1999;36:75–87.
    1. Tang AM, Graham NM, Chandra RK, Saah AJ. Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr. 1997;127:345–351.
    1. Robertson KR, Stern RA, Hall CD, Perkins DO, Wilkins JW, et al. Vitamin B12 deficiency and nervous system disease in HIV infection. Arch Neurol. 1993;50:807–811.
    1. Nakimuli-Mpungu E, Musisi S, Kiwuwa Mpungu S, Katabira E. Early-onset versus late-onset HIV-related secondary mania in Uganda. Psychosomatics. 2008;49:530–534.
    1. Nakimuli-Mpungu E, Musisi S, Mpungu SK, Katabira E. Primary mania versus HIV-related secondary mania in Uganda. Am J Psychiatry 163: 1349–1354; quiz 1480. 2006.
    1. Smith Fawzi MC, Kaaya SF, Mbwambo J, Msamanga GI, Antelman G, et al. Multivitamin supplementation in HIV-positive pregnant women: impact on depression and quality of life in a resource-poor setting. HIV Med. 2007;8:203–212.
    1. Remacha AF, Cadafalch J, Sarda P, Barcelo M, Fuster M. Vitamin B-12 metabolism in HIV-infected patients in the age of highly active antiretroviral therapy: role of homocysteine in assessing vitamin B-12 status. Am J Clin Nutr. 2003;77:420–424.
    1. Baum MK, Shor-Posner G, Lu Y, Rosner B, Sauberlich HE, et al. Micronutrients and HIV-1 disease progression. AIDS. 1995;9:1051–1056.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅